The stylized Acorda logo is a registered trademark of Acorda Therapeutics®, Inc. The stylized path logo is a trademark of Acorda Therapeutics®, Inc. ©2011 Acorda Therapeutics®, Inc. All rights reserved.
My shoes look
forward to taking
AMPYRA® (dalfampridine) is indicated as
a treatment to improve walking in patients with
multiple sclerosis (MS). This was demonstrated
by an increase in walking speed.
AMPYRA is an oral tablet,
not an infusion or injection
AMPYRA can be used in any of the
four major types of MS
AMPYRA can be taken alone or
with other MS medications
AMPYRA improved walking in significantly more
people than placebo in 2 clinical trials ( 34.8% vs.
8.3% and 42.9% vs. 9.3%)
AMPYRA does not work for everyone.
Please talk to your doctor to see if AMPYRA is right for you.
IMPORTANT SAFETY INFORMATION:
Talk to your doctor about AMPYRA to learn if it is right for you. Do not take it if you’ve ever had a seizure
or if you have certain types of kidney problems as this may increase your risk of seizure. Tell your doctor
if you have kidney problems.
Never take more than one tablet of AMPYRA twice a day (about 12 hours apart). Don’t take more than
2 tablets in a 24-hour period because it may increase the risk of seizures. If you miss a dose of AMPYRA
don’t make up the missed dose.
Do not take AMPYRA together with other aminopyridine medications including compounded
4-aminopyridine (sometimes called 4-AP, fampridine).
AMPYRA may cause serious side effects including kidney or bladder infections. The most common side
effects are urinary tract infection, trouble sleeping (insomnia), dizziness, headache, nausea, weakness,
back pain and problems with balance. Tell your doctor if you have any of these side effects that bother
you or do not go away.
This is not the full safety information. For more information, please refer to the Medication Guide on the
next page. This important safety information is not meant to replace discussions with your doctor.
For more information call toll-free 1-888-881-1918.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
AMP YRA® is a registered trademark of Acorda Therapeutics®, Inc.
AMP YRA® is marketed by Acorda Therapeutics®, Inc. and manufactured under license from Elan Pharma International Ltd.